US$ 28.44
bpc 157 hair transplant Peptide Therapy for Growth: Does It Really Work? Hair Transplant at 23 years
Description
Retatrutide is an investigational triple GLP-1/GIP/glucagon receptor agonist not approved by the MHRA or EMA
For maintenance therapy in individuals with dietary deficiency, doses of 50150 micrograms daily are often sufficient and better tolerated

Independently tested for endotixins, sterility and benzyl alcohol level.

Newly Added Key Studies: Yasui et al
